Patents by Inventor Kyu-Heum Na

Kyu-Heum Na has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240000854
    Abstract: A method for producing high-concentration stem cell exosomes with enhanced anti-inflammatory function using Lipopolysaccharide (LPS) and/or Lipoteichoic Acid (LTA), as well as anti-inflammatory and/or regenerative compositions that can be produced by the aforementioned method are disclosed. The production method for the anti-inflammatory composition includes a first step of treating stem cells during cultivation with one or more selected from a group consisting of Lipopolysaccharide (LPS) and Lipoteichoic Acid (LTA), and optionally, a second step of separating stem cells, their culture medium, and/or their exosomes obtained as a result of the first step.
    Type: Application
    Filed: December 6, 2021
    Publication date: January 4, 2024
    Applicant: PRIMORIS THERAPEUTICS Co., Ltd.
    Inventors: Jae-yong LEE, Hee-jin AHN, Yea-in LEE, Dong-yeol LEE, Kyu-heum NA
  • Publication number: 20230406897
    Abstract: A method for isolating and culturing umbilical cord blood stem cells that express high levels of GDF-3 is disclosed. Umbilical cord blood stem cells isolated and cultured as described herein exhibit high expression of GDF-3. Stem cells with high expression of GDF-3 maintain high proliferation capacity contrary to conventional stem cells even as passages progress, allowing for the advantage of obtaining a large quantity of healthy stem cells. Furthermore, due to the higher proliferation rate of stem cells, it has been observed that the concentration of extracellular matrix components secreted by the cells is also higher. Therefore, when utilizing GDF-3 high-expressing umbilical cord blood stem cells for the production of cell and culture medium compositions, it is possible to produce raw materials with excellent efficacy and effects.
    Type: Application
    Filed: December 6, 2021
    Publication date: December 21, 2023
    Applicant: PRIMORIS THERAPEUTICS Co., Ltd.
    Inventors: Jae-yong LEE, Hee-jin AHN, Yea-in LEE, Dong-yeol LEE, Kyu-heum NA
  • Publication number: 20060223144
    Abstract: The present invention relates to a method for mass-production of human follicle stimulating hormone, more precisely, to an expression vector containing human follicle stimulating hormone gene, a transformant transfected with the expression vector and a method for mass-production of human follicle stimulating hormone by using the same. Human follicle stimulating hormone can be produced largely by using an expression vector and a transformant of the present invention. Therefore the expression vector and the transformant of the present invention can be effectively used for the treatment of infertility.
    Type: Application
    Filed: September 24, 2004
    Publication date: October 5, 2006
    Applicant: Progen Co., Ltd.
    Inventors: Se Hwan Yang, Young Chul Sung, Kyu-Heum Na, Sung Hee Lee, Won Bae Kim